Double-blind, randomized clinical trial for safety and efficacy of Norfloxacin for Shigellosis in children

Bhattacharya, S. K. ; Bhattacharya, M. K. ; Dutta, D. ; Dutta, S. ; Deb, M. ; Deb, A. ; Das, K. P. ; Koley, H. ; Nair, G. B. (1997) Double-blind, randomized clinical trial for safety and efficacy of Norfloxacin for Shigellosis in children Acta Paediatrica, 86 (3). pp. 319-320. ISSN 1651-2227

Full text not available from this repository.

Official URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1651-...

Related URL: http://dx.doi.org/10.1111/j.1651-2227.1997.tb08898.x

Abstract

In a randomized, double-blind clinical trial, the efficacy and safety of norfloxacin were compared with nalidixic acid in the treatment of shigellosis in children. Out of 59 cases, Shigella spp. were isolated from 8 cases in the nalidixic acid group and 14 cases in the norfloxacin group. The norfloxacin group had significantly less duration of diarrhoea and presence of blood in stool as compared to the nalidixic acid group. No joint problem was encountered in this study at up to 4 months follow-up. Norfloxacin is safe and effective and showed no cartilage toxicity on short-term follow-up.

Item Type:Article
Source:Copyright of this article belongs to John Wiley and Sons.
Keywords:Norfloxacin; Shigellosis; Toxicity; Children
ID Code:84277
Deposited On:24 Feb 2012 15:38
Last Modified:24 Feb 2012 15:38

Repository Staff Only: item control page